What is Gyre Therapeutics, Inc.'s change in AR?

Gyre Therapeutics, Inc. (GYRE) reported change in AR of -$8.57M in Q1 2026.

How has Gyre Therapeutics, Inc.'s change in AR changed year-over-year?

Gyre Therapeutics, Inc.'s change in AR decreased by 1287.4% year-over-year, from $722K to -$8.57M.

What does change in AR mean?

Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.

Gyre Therapeutics, Inc. GYRE Change in AR

Change in AR at other companies

Madrigal Pharmaceuticals, Inc.MDGL

$52.88M+595%

Rigel PharmaceuticalsRIGL

-$1.82M-2,574%

BridgeBio PharmaBBIO

$65.78M-40.5%

Opko HealthOPK

-$9.53M+58.5%

Syndax PharmaceuticalsSNDX

-$120K-101%

PrecigenPGEN

$22.49M+12,950%

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s change in AR?: Gyre Therapeutics, Inc. (GYRE) reported change in AR of -$8.57M in Q1 2026.
How has Gyre Therapeutics, Inc.'s change in AR changed year-over-year?: Gyre Therapeutics, Inc.'s change in AR decreased by 1287.4% year-over-year, from $722K to -$8.57M.
What does change in AR mean?: Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.